U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07860112) titled 'Vonoprazan-Amoxicillin Dual Therapy for Helicobacter Pylori Infection in United States Adolescents' on Sept. 11.
Brief Summary: Helicobacter pylori (H. pylori) is a common bacterial infection of the stomach that can cause chronic stomach inflammation, ulcers, and other digestive problems. The infection is more common among some racial and ethnic minority groups and people from lower-income households, contributing to ongoing health disparities.
Current treatment for H. pylori usually requires multiple medications, including antibiotics and acid-suppressing drugs. However, increasing antibiotic resistance has made some standard treat...